UT MD Anderson and Nature to co-host conference on next-generation cancer therapeutics
In-person conference runs Oct. 6-8, 2026, with registration open until Oct. 5, 2026
Topics include next-generation cancer therapeutics and immunotherapies, protein modulators, emerging platforms and artificial intelligence models
HOUSTON, SEPTEMBER 15, 2026 ― The University of Texas MD Anderson Cancer Center and Springer Nature will co-host a conference to explore the latest research on cancer therapeutics, highlighting advances in...
UT MD Anderson honors visionary leadership of Dr. Peter Pisters following retirement announcement; shares transition plans
The University of Texas MD Anderson Cancer Center today is recognizing the exceptional leadership of Peter WT Pisters, M.D., president, following...
UT MD Anderson ranks No. 1 in the nation for cancer care for 12th year in a row
Ranking reflects commitment to excellence in evidence-based cancer care
Two specialties receive national rankings, and six procedures...
UT MD Anderson joins global consortium committed to eliminating cervical cancer
The University of Texas MD Anderson Cancer Center today announced it has joined a global consortium dedicated to accelerating the elimination of cervical cancer worldwide. The collaboration agreement with the Elimination Partnership in Cervical Cancer (EPICC) expands UT MD Anderson’s global oncology efforts, further strengthening its commitment to advancing cancer prevention and control in medically underserved regions.
The ...
ASCO: UT MD Anderson faculty honored as 2026 Special Award recipients
Sharon Giordano will receive the Gianni Bonadonna Breast Cancer Award for significant contributions to breast cancer care and research ...
UT MD Anderson names Albert Koong, M.D., Ph.D., chief scientific officer
The University of Texas MD Anderson Cancer Center today announced that Albert Koong, M.D., Ph.D., an internationally recognized physician-scientist...
CPRIT awards UT MD Anderson over $19 million for cancer research and faculty recruitment
The University of Texas MD Anderson Cancer Center today was awarded over $19 million from the Cancer Prevention and Research Institute of...
Novel CAR T cell therapy developed by UT MD Anderson researchers moves into clinical studies
The novel therapy targets CD94+ relapsed or refractory T/NK cell lymphomas
UT MD Anderson received Investigational New Drug clearance from the...
UT MD Anderson appoints Kim Slusser as chief nurse executive
The University of Texas MD Anderson Cancer Center today announced the appointment of Kim Slusser, Ph.D., R.N., as the institution’s inaugural...
UT MD Anderson establishes Center for Cellular Language Intelligence with $10 million gift from Peggy and Carl Sewell
The University of Texas MD Anderson Cancer Center today announced a $10 million gift from Peggy and Carl Sewell to...